Tachykinin antagonists for the treatment of asthma, gastrointestinal disease and central nervous system disease

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.4, 1997-04, pp. : 389-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Eugenol on the Central Nervous System: Its Possible Application to Treatment of Alzheimer's Disease, Depression, and Parkinson's Disease

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 57-66

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and Their Receptors in Central Nervous System Disease

Current Drug Targets, Vol. 7, Iss. 1, 2006-01 ,pp. : 29-46

Bentham Science Publishers

Access to resources Recommend Favorite

Tachykinin receptor antagonists for asthma and COPD

By Rogers Duncan F

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. : 1097-1121

Informa Healthcare

Access to resources Recommend Favorite

Trigonelline: A Plant Alkaloid with Therapeutic Potential for Diabetes and Central Nervous System Disease

Current Medicinal Chemistry, Vol. 19, Iss. 21, 2012-07 ,pp. : 3523-3531

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory T Cells in Central Nervous System: in Health and Disease

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 10, Iss. 4, 2010-12 ,pp. : 326-336

Bentham Science Publishers

Access to resources Recommend Favorite